144 related articles for article (PubMed ID: 35290889)
1. A novel brain-penetrant oral UGT8 inhibitor decreases in vivo galactosphingolipid biosynthesis in murine Krabbe disease.
Zaccariotto E; Cachón-González MB; Wang B; Lim S; Hirth B; Park H; Fezoui M; Sardi SP; Mason P; Barker RH; Cox TM
Biomed Pharmacother; 2022 May; 149():112808. PubMed ID: 35290889
[TBL] [Abstract][Full Text] [Related]
2. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
3. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.
Li Y; Xu Y; Benitez BA; Nagree MS; Dearborn JT; Jiang X; Guzman MA; Woloszynek JC; Giaramita A; Yip BK; Elsbernd J; Babcock MC; Lo M; Fowler SC; Wozniak DF; Vogler CA; Medin JA; Crawford BE; Sands MS
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20097-20103. PubMed ID: 31527255
[TBL] [Abstract][Full Text] [Related]
4. Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease.
Won JS; Kim J; Paintlia MK; Singh I; Singh AK
Brain Res; 2013 May; 1508():44-52. PubMed ID: 23438514
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides.
Ichioka T; Kishimoto Y; Brennan S; Santos GW; Yeager AM
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4259-63. PubMed ID: 2884662
[TBL] [Abstract][Full Text] [Related]
6. Developmental defects and aberrant accumulation of endogenous psychosine in oligodendrocytes in a murine model of Krabbe disease.
Inamura N; Kito M; Go S; Kishi S; Hosokawa M; Asai K; Takakura N; Takebayashi H; Matsuda J; Enokido Y
Neurobiol Dis; 2018 Dec; 120():51-62. PubMed ID: 30176352
[TBL] [Abstract][Full Text] [Related]
7. Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination.
Watanabe T; Tsuboi K; Matsuda N; Ishizuka Y; Go S; Watanabe E; Ono A; Okamoto Y; Matsuda J
J Neurochem; 2023 Aug; 166(4):720-746. PubMed ID: 37337846
[TBL] [Abstract][Full Text] [Related]
8. Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
Graziano AC; Parenti R; Avola R; Cardile V
Apoptosis; 2016 Jan; 21(1):25-35. PubMed ID: 26459425
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
10. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis.
Svennerholm L; Vanier MT; Månsson JE
J Lipid Res; 1980 Jan; 21(1):53-64. PubMed ID: 7354254
[TBL] [Abstract][Full Text] [Related]
11. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death.
Giri S; Khan M; Rattan R; Singh I; Singh AK
J Lipid Res; 2006 Jul; 47(7):1478-92. PubMed ID: 16645197
[TBL] [Abstract][Full Text] [Related]
12. Reduction in miR-219 expression underlies cellular pathogenesis of oligodendrocytes in a mouse model of Krabbe disease.
Inamura N; Go S; Watanabe T; Takase H; Takakura N; Nakayama A; Takebayashi H; Matsuda J; Enokido Y
Brain Pathol; 2021 Sep; 31(5):e12951. PubMed ID: 33822434
[TBL] [Abstract][Full Text] [Related]
13. β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and
Coltrini D; Chandran AMK; Belleri M; Poliani PL; Cominelli M; Pagani F; Capra M; Calza S; Prioni S; Mauri L; Prinetti A; Kofler JK; Escolar ML; Presta M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012705
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach.
Esch SW; Williams TD; Biswas S; Chakrabarty A; LeVine SM
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):779-87. PubMed ID: 14528915
[TBL] [Abstract][Full Text] [Related]
15. A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice.
Pannuzzo G; Cardile V; Costantino-Ceccarini E; Alvares E; Mazzone D; Perciavalle V
Mol Genet Metab; 2010 Jul; 100(3):234-40. PubMed ID: 20418135
[TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of spontaneously immortalized Schwann cells from murine model of globoid cell leukodystrophy (twitcher).
Shen JS; Watabe K; Meng XL; Ida H; Ohashi T; Eto Y
J Neurosci Res; 2002 Jun; 68(5):588-94. PubMed ID: 12111848
[TBL] [Abstract][Full Text] [Related]
18. Murine, canine and non-human primate models of Krabbe disease.
Wenger DA
Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
[TBL] [Abstract][Full Text] [Related]
19. Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture.
White AB; Givogri MI; Lopez-Rosas A; Cao H; van Breemen R; Thinakaran G; Bongarzone ER
J Neurosci; 2009 May; 29(19):6068-77. PubMed ID: 19439584
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy.
Qin EY; Hawkins-Salsbury JA; Jiang X; Reddy AS; Farber NB; Ory DS; Sands MS
Mol Genet Metab; 2012 Sep; 107(1-2):186-96. PubMed ID: 22704480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
